Showing results (801-810 of 3,353) with videos related to

Sort By:
Pageof 336
The Lancet. Oncology|March 28, 2024
Cancer control collaborations between China and African countriesTwalib Ngoma, Isaac Adewole, Victoria Ainsworth, et al.
The Lancet. Oncology|March 28, 2024
Optimal targeting of PI3K-AKT and mTOR in advanced oestrogen receptor-positive breast cancerIseult M Browne, Fabrice André, Sarat Chandarlapaty, et al.
The Lancet. Oncology|March 28, 2024
Gedatolisib in combination with palbociclib and endocrine therapy in women with hormone receptor-positive, HER2-negative advanced breast cancer: results from the dose expansion groups of an open-label, phase 1b studyRachel M Layman, Hyo S Han, Hope S Rugo, et al.
The Lancet. Oncology|March 11, 2024
Activity of venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia: analysis of the VENICE-1 multicentre, open-label, single-arm, phase 3b trialArnon P Kater, Önder Arslan, Fatih Demirkan, et al.
The Lancet. Oncology|October 3, 2024
Development of a conceptual framework for an electronic patient-reported outcome (ePRO) system measuring symptoms and impacts of CAR T-cell therapies in patients with haematological malignanciesForam Khatsuria, Christel McMullan, Olalekan Lee Aiyegbusi, et al.
The Lancet. Oncology|September 13, 2024
Atezolizumab, venetoclax, and obinutuzumab combination in Richter transformation diffuse large B-cell lymphoma (MOLTO): a multicentre, single-arm, phase 2 trialAlessandra Tedeschi, Anna Maria Frustaci, Adalgisa Condoluci, et al.
The Lancet. Oncology|February 29, 2024
Deep-learning-based reconstruction of undersampled MRI to reduce scan times: a multicentre, retrospective, cohort studyAditya Rastogi, Gianluca Brugnara, Martha Foltyn-Dumitru, et al.
The Lancet. Oncology|November 17, 2023
The future of cancer care in the UK-time for a radical and sustainable National Cancer PlanAjay Aggarwal, Ananya Choudhury, Nicola Fearnhead, et al.
The Lancet. Oncology|November 9, 2023
Performance of the WID-qEC test versus sonography to detect uterine cancers in women with abnormal uterine bleeding (EPI-SURE): a prospective, consecutive observational cohort study in the UKIona Evans, Daniel Reisel, Allison Jones, et al.
The Lancet. Oncology|November 12, 2023
Optimising follow-up strategy based on cytology and human papillomavirus after fertility-sparing surgery for early stage cervical cancer: a nationwide, population-based, retrospective cohort studyTeska N Schuurman, Mirte Schaafsma, Kaylee H To, et al.
Pageof 336